Once-daily budesonide inhalation powder (Pulmicort Turbuhaler®) is effective and safe in adults previously treated with inhaled corticosteroids

Journal of Asthma

Volumn 39, Issue 1, 2002, Pages 65-75

  Metzger, W James ^a   Hampel Jr , Frank C ^a   Sugar, Mark ^a  

^a Allergy & Asthma Associates of Southern California   (United States)

Author keywords

Asthma; Budesonide; Dry powder inhaler; Inhaled corticosteroid; Once daily; Pulmicort Turbuhaler

Indexed keywords

BUDESONIDE; PLACEBO;

ARTICLE; ASTHMA; BRONCHOSPASM; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; NAUSEA; PAIN; PHARYNGITIS; POWDER INHALER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RHINITIS; SCORING SYSTEM; SINUSITIS; STEROID THERAPY; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BUDESONIDE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; POWDERS;

EID: 0036190294     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120000808     Document Type: Article

References (29)

1. Airway remodelling takes place in asthma - What are the clinical implications?
2. Refractory asthma, Part I: Epidemiology, pathophysiology, pharmacologic interventions
3. Inhaled glucocorticoids for asthma
4. Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis
5. Budesonide delivered by turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma
6. Rapid onset of control with budesonide turbuhaler in patients with mild to moderate asthma
7. Oral glucocorticosteroid-sparing effect of budesonide administered by turbuhaler: A double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma
8. Lung deposition of budesonide from turbuhaler® is twice that from a Pressurized Metered-Dose Inhaler PMDI
9. Importance of the inhalation device on the effect of budesonide
10. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma
11. Compliance with inhaled therapy and morbidity from asthma
12. Compliance in clinical trials of two nonbronchodilator, antiasthma medications
13. Compliance and outcomes in patients with asthma
14. Maintaining long-term control of blood pressure: The role of improved compliance
15. Once-daily versus twice-daily dosing of theophylline. A decision analysis approach to evaluating theophylline blood levels and compliance
16. A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide
17. Standards for the diagnosis and care of patients with Chronic Obstructive Pulmonary Diseases (COPD) and asthma
18. Evaluation of impairment of health related quality of life in asthma: Development of a questionnaire for use in clinical trials
19. Determining a minimal important change in a disease-specific quality of life questionnaire
20. Interpreting treatment effects in randomized trials
21. Assessing the minimal important difference in symptoms: A comparison of two techniques
22. Administration of budesonide once-a-day via turbuhaler® to subjects with stable asthma
23. Once-daily budesonide 400 micrograms once daily is as effective as 200 micrograms twice daily in controlling childhood asthma
24. Once-daily budesonide in mild asthma
25. Psychological factors associated with medication nonadherence in asthmatic children
26. Nonadherence in asthmatic patients: Is there a solution to the problem?
27. Measuring compliance with inhaled medication in asthma
28. Once daily budesonide (Pulmicort Turbuhaler®) improves quality of life in adult asthmatics previously treated with inhaled corticosteroids